Apparatus and method for treating venous reflux

Information

  • Patent Grant
  • 7294126
  • Patent Number
    7,294,126
  • Date Filed
    Monday, January 5, 2004
    21 years ago
  • Date Issued
    Tuesday, November 13, 2007
    17 years ago
Abstract
Disclosed is an ablation method and apparatus used to close veins for treatment of venous insufficiency disease. The apparatus includes a catheter proportioned for insertion into a vein, a pair of inflatable balloons spaced apart on the catheter body, and an ablation electrode array disposed between the balloons. According to the disclosed method, the catheter is introduced into the vein to be treated and the balloons are distended. Blood is flushed and aspirated from the site between the balloons. RF power is applied to the electrode array, causing scarring of the vessel walls and eventual sealing of the vein.
Description
FIELD OF THE INVENTION

The present invention relates generally to the field of apparatuses and methods for treating body tissue, and specifically to apparatuses and methods for treating interior surfaces of blood vessels.


BACKGROUND OF THE DISCLOSURE

Veins of the lower extremities are equipped with a series of one-way bicuspid valves that pulse open and closed. These valves facilitate flow of venous blood towards the heart and prevent venous blood from flowing away from the heart. In a condition known as venous insufficiency, defective valves do not close properly, resulting in venous reflux (backward flow of blood within the veins). Venous reflux can result in pooling of blood within the veins, and can lead to pain, swelling, ulcers, and varicose veins.


Venous reflux disease (VRD) most commonly occurs in the saphenous vein. Current treatments for VRD involve re-routing of blood from the affected vein into the nearby vasculature. In one such treatment, known as venous stripping, the long and/or short saphenous vein is removed. Another treatment for VRD involves suture ligation of the long and/or short saphenous vein. More recently other methods have been developed, including the application of RF energy to the interior of the vein, but the method is slow, requiring 30 minutes to an hour to perform, and is tedious for the physician to perform since it requires a constant, slow withdrawal of the device from the vein during the application of energy. These detriments make it impractical to perform in the clinic.


SUMMARY OF THE INVENTION

The present invention is an ablation method and apparatus used to close veins. An apparatus according to the present invention includes a catheter proportioned for insertion into a vein, a pair of inflatable balloons spaced apart on the catheter body, and an ablation electrode array disposed between the balloons. According to the disclosed method, the catheter is introduced into the vein to be treated and the balloons are distended. Blood is flushed and aspirated from the site between the balloons. RF power is applied to the electrode array, causing scarring of the vessel walls and eventual sealing of the vein. A pressure bandage may be applied around the patient's leg post-operatively for a short time to facilitate scarring and sealing.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a side elevation view of an ablation catheter for treatment of venous reflux disease;



FIG. 1B is a cross-sectional side view of the catheter of FIG. 1A, taken along the plane designated 1B—1B in FIG. 1A.



FIG. 2 is a block diagram of an ablation system utilizing the catheter of FIG. 1A;





DETAILED DESCRIPTION

Referring to FIGS. 1A and 1B, an ablation catheter 10 includes a catheter body 12, which is preferably an extrusion formed of a flexible polymeric material suitable for surgical use. Body 12 preferably includes three fluid lumens 14, 16, 18, of which lumens 16 and 18 are open to one another at the distal region of the catheter body 12. A central guidewire lumen 19 extends from the proximal end to the distal end of the catheter and receives a guidewire 21.


A pair of spaced-apart balloons 20 is disposed on the catheter body 12. The balloons are formed of an elastic or inelastic material. Each balloon is fluidly coupled to lumen 14 via small inflation openings 22 formed in the body 12. The proximal end of the lumen 14 terminates at an inflation port 24 that couples to a source of inflation medium for inflation and deflation of the balloons 20. The balloons are preferably sealed against the catheter body 12 such that when they are inflated they do not leak inflation medium directly into the vein. Lumen 14 itself is collapsible when a vacuum is applied to it.


An electrode array 26 is positioned on the catheter body 12 between the balloons 20. The array 26 includes one or more bipolar electrode pairs 28 preferably formed over the circumference of the catheter body. In a preferred configuration, the array extends along a sufficient length of catheter to permit simultaneous ablation of the full length of the targeted region of the vein. This avoids the need for repositioning the catheter within the vein, or for dragging the energized electrode through the vein to ablate the desired length of the vessel.


The electrodes preferably are constructed of a thin layer deposit using a conductive metal, for instance silver or gold. In another preferred embodiment the electrodes are constructed of a fine elastic conductive mesh with integrated insulating and conducting regions. An electrode mesh of this type is utilized on the NovaSure® Endometrial Ablation System sold by Novacept, Inc. of Palo Alto, Calif.


Insulated electrode leads (not shown) extend from the electrode pairs and through the catheter body 12, and are coupled to a cable 42 that interfaces with a RF controller 44 (FIG. 2). Preferably, the RF controller 44 includes RF circuitry 45 having both low and high impedance transformation circuits, and automatically selects the impedance circuit based on real time measured impedance of the ablation electrode in contact with the vessel tissue. An impedance-matched RF generator system of this type is described in International Application No. PCT/US99/09904, Filed May 7, 1999, and entitled A RADIO-FREQUENCY GENERATOR FOR POWERING AN ABLATION DEVICE, the entirety of which is incorporated herein by reference. An RF controller employing such impedance-matching technology for ablation applications is the NovaSure® RF Controller sold by Novacept, Inc. of Palo Alto, Calif.


The center-to-center spacing C between the electrodes (i.e. the distance between the centers of adjacent electrodes), the distance between the electrodes, and the widths of the electrodes are selected so that ablation will reach predetermined depths within the tissue, particularly when controlled power is delivered through the electrodes (where power density is the power delivered per unit surface area at which low impedance, low voltage ablation can be achieved).


The depth of ablation is also affected by the electrode density (i.e., the percentage of the target tissue area which is in contact with active electrode surfaces) and may be regulated by pre-selecting the amount of this active electrode coverage. For example, the depth of ablation is much greater when the active electrode surface covers more than 10% of the target tissue than it is when the active electrode surfaces covers 1% of the target tissue.


Although the electrodes shown in the drawings are arranged in a particular pattern, it should be appreciated that the electrodes may be arranged in any pattern that will result in ablation to desired depths.


In one embodiment, the electrode spacing is approximately 0.5–1.0 mm with the active electrode surfaces covering approximately 10% of the target region. Delivery of approximately 8–10 watts of power per centimeter squared of tissue surface area using this electrode configuration will achieve ablation to a depth of approximately 0.1–2.5 mm. After reaching this ablation depth, the impedance of the tissue will become so great that ablation will self-terminate as described with respect to the operation of the system.


The proximal end of lumen 18 bifurcates into two sections of tubing 34, 36. First section 34 terminates at a vacuum relief valve 38 that regulates the vacuum level within the catheter. Second section 36 terminates at a flush port 40 that is connectable to a source of saline or other fluid that may be injected into the vein via perforations 30. Flush port 40 may also be coupled to a vacuum monitoring circuit 48, which detects the pressure within the lumen 16, 18 so as to monitor to amount of vacuum applied. In one embodiment, the vacuum pump 46 and vacuum monitoring circuit 48 may be housed within the RF controller 44, as shown in FIG. 2.


A plurality of pores/perforations 30 is formed in the catheter body 12, between balloons 20 as shown. If the array is formed of a mesh, the perforations may be the interstices of the mesh. The perforations are fluidly coupled to fluid lumens 16, 18—which may be contiguous with one other at the distal portion of the catheter body. The proximal end of lumen 16 terminates at a suction port 32 that is connectable to a vacuum pump 46. Thus, application of a vacuum to lumen 16 draws moisture and fluid through the perforations 30, through lumen 16 of the catheter body 12 and out the proximal end of the catheter body. The vacuum signal is transmitted up lumen 18, through connection 40, to the pressure transducer in the vacuum monitoring circuit 48 in the RF Controller. The vacuum monitoring circuit assures the target tissue is under the appropriate vacuum limits at appropriate times throughout the procedure. Application of a vacuum also facilitates electrode-tissue contact by drawing tissue into contact with the electrodes.


One preferred method of using the ablation catheter 10 will next be described. First, an incision is made to expose the vessel to be treated. For the saphenous vein or long saphenous vein, the incision is formed in the patient's groin. Guidewire 21 is inserted into the vein and the catheter is advanced over the guidewire 21 into the desired position within the vein. Balloons 20, 22 are inflated into contact with the interior wall of the vein, using an inflation medium introduced through port 24 and lumen 14. A flushing medium, preferably saline, is directed into flush port 40 and exits the catheter via perforations 30 where it functions to flush the region of the vessel between the balloons. It may be desirable to initiate this flow of saline prior to, or simultaneously with, insertion of the catheter to prevent blood from clogging pores/perforations 30. Suction is applied via vacuum port 32 to aspirate the mixture of saline and blood from the vein, through perforations 30 and out of the catheter. The suction in this step is preferably insufficient to collapse the vein. Flushing and aspiration are continued until much of the blood is removed from the vein, although some blood may remain in the vein without impairing operation of the catheter. A slight positive pressure, sufficient to overcome venous pressure, is maintained on the system after the flushing process is complete in order to maintain patency in perforations 30 and lumens 16 and 18.


Next, the RF controller 44 energizes the electrode array 26 to deliver ablation energy to the surrounding tissue. Suction is preferably applied to the vacuum port 32 during ablation for two reasons. First, suction collapses the vessel, thus drawing the interior wall of the vessel into contact with the electrode array. Second, suction draws moisture (gas and vapor) away from the ablation site. Moisture build-up at the ablation site may be detrimental in that it provides a conductive layer that carries current from the electrodes even when ablation has reached the desired depth. This undesirable continued current flow heats the moisture and surrounding tissue, and thus causes ablation to continue by unpredictable thermal conduction means.


Ablation causes tissue to dehydrate and thus to decrease in conductivity. By applying a vacuum or otherwise shunting moisture away from the ablation site, and thus preventing liquid build-up, there is no liquid conductor at the ablation area during use of the ablation device of the present invention. Thus, when ablation has reached the desired depth, the impedance at the tissue surface becomes sufficiently high to stop or nearly stop the flow of current into the tissue. RF ablation thereby stops and thermal ablation does not occur in significant amounts. If the RF controller is equipped with an impedance monitor, a physician utilizing the ablation device can monitor the impedance at the electrodes and will know that ablation has self-terminated once the impedance rises to a certain level. Alternatively the impedance monitor may automatically shut down power delivery after the desired impedance has been reached, and display a message or signal a type of indicator to notify the physician that the procedure is complete. By contrast, in the absence of moisture removal, the presence of liquid around the bipolar electrodes would cause the impedance monitor to give a low impedance reading regardless of the depth of ablation which had already been carried out, since current would continue to travel through the low-impedance liquid layer.


Collagen and elastin in the vessel wall may shrink during power application, collapsing the vessel down onto the catheter. Once ablation has self-terminated and/or ablation has been performed to the desired depth, delivery of RF energy to the electrodes is terminated. Relieving the pressure at connector 24 deflates balloons 20. Applying a vacuum to connector 24 then collapses lumen 14, reducing the size of the catheter to facilitate removal. The catheter is then removed from the vein. A compression bandage is applied to patient over the site of the ablation, so as to hold opposing portions of the ablated vessel in contact with one another. This causes the ablated portions of the vessel to seal against one another, thus closing the vessel and causing blood flow be diverted to surround vessels.

Claims
  • 1. A device for sealing a blood vessel, comprising: a catheter having an elongate body positionable within a blood vessel, the elongate catheter body selectively collapsible to a reduced diameter configuration to facilitate movement of the catheter within a blood vessel;a pair of inflatable balloon members on the elongate body, the balloon members expandable into contact with an interior wall of the blood vessel;a bipolar electrode array on the elongate body between the balloons;at least one opening in the elongate body, between the balloons;a source of flushing fluid coupled to the opening;a vacuum source fluidly coupled to the opening, the vacuum source providing sufficient vacuum pressure to aspirate blood and flushing fluid out of the blood vessel through the opening; anda source of ablation energy electrically coupled to the electrode array such that energization of the electrode array causes ablation of blood vessel tissue in contact with the electrode array.
  • 2. The device of claim 1 wherein the vacuum source is further operable to draw the interior wall of the blood vessel into contact with the electrode array.
  • 3. The device of claim 1 wherein the vacuum source is further operable to draw moisture generated during ablation away from the tissue and into the elongate body.
  • 4. The device of claim 1 wherein the at least one opening comprises a plurality of openings in the elongate body.
  • 5. The device of claim 1 wherein the source of ablation energy includes an RF generator having a low impedance transformation circuit and a high impedance transformation circuit, an impedance detection circuit for measuring impedance of tissue in contact with the electrode array, and a control circuit for automatically selecting between the low impedance transformation circuit and the high impedance transformation circuit based on the impedance of the tissue in contact with the electrode array.
  • 6. The device of claim 5 wherein the control circuit is for selecting the transformation circuit having an impedance closest to the measured impedance of the tissue in contact with the electrode array.
  • 7. The device of claim 1, wherein the catheter includes a collapsible lumen, the lumen collapsible after ablation to place the catheter in the reduced-diameter configuration and to facilitate removal of the catheter from the vessel.
  • 8. A device for sealing a blood vessel, comprising: a catheter having an elongate body positionable within a blood vessel, the elongate catheter body selectively collapsible to a reduced diameter configuration to facilitate movement of the catheter within a blood vessel, the catheter including a collapsible lumen;a pair of inflatable balloon members on the elongate body, the balloon members expandable into contact with an interior wall of the blood vessel;an electrode array on the elongate body between the balloons;at least one opening in the elongate body, between the balloons;a source of flushing fluid coupled to the opening;a vacuum source fluidly coupled to the opening, the vacuum source providing sufficient vacuum pressure to aspirate blood and flushing fluid out of the blood vessel through the opening the vacuum source fluidly coupled to the collapsible lumen; anda source of ablation energy electrically coupled to the electrode array such that energization of the electrode array causes ablation of blood vessel tissue in contact with the electrode array.
  • 9. The device of claim 1, wherein the device includes a compression device positionable exteriorly of the blood vessel for compression of the blood vessel following ablation, said compression sufficient to cause opposed ablated regions of the interior wall to seal against one another.
  • 10. A device for sealing a blood vessel, comprising: a catheter having an elongate body positionable within a blood vessel;a pair of inflatable balloon members on the elongate body, the balloon members expandable into contact with an interior wall of the blood vessel;an electrode array on the elongate body between the balloons;at least one opening in the elongate body, between the balloons;a source of ablation energy electrically coupled to the electrode array such that energization of the electrode array causes ablation of blood vessel tissue in contact with the electrode array; anda vacuum source fluidly coupled to the opening, the vacuum source operable during ablation of blood vessel tissue to substantially prevent formation of a low impedance liquid layer around the electrodes when ablation is carried out using the electrodes.
  • 11. The device of claim 10 wherein the electrode array is a bipolar electrode array.
Parent Case Info

This divisional application claims the benefit of U.S. patent application Ser. No. 10/052,157, filed Jan. 16, 2002, which has issued as U.S. Pat. No. 6,712,815, and which also claims the benefit of U.S. Provisional Application No. 60/261,321 filed Jan. 16, 2001. INVENTORS: Russell M. Sampson, Eugene Skalnyi, M D, both of Mountain View, Calif.; Estela Hilario of Los Altos, Calif.

US Referenced Citations (34)
Number Name Date Kind
4601713 Fuqua Jul 1986 A
5047028 Qian Sep 1991 A
5078717 Parins et al. Jan 1992 A
5318532 Frassica Jun 1994 A
5405322 Lennox et al. Apr 1995 A
5588961 Leone et al. Dec 1996 A
5609598 Laufer et al. Mar 1997 A
5730136 Laufer et al. Mar 1998 A
5769880 Truckai et al. Jun 1998 A
5810847 Laufer et al. Sep 1998 A
5938660 Swartz et al. Aug 1999 A
6014589 Farley et al. Jan 2000 A
6033397 Laufer et al. Mar 2000 A
6036687 Laufer et al. Mar 2000 A
6071277 Farley et al. Jun 2000 A
6077257 Edwards et al. Jun 2000 A
6117101 Diederich et al. Sep 2000 A
6135997 Laufer et al. Oct 2000 A
6139527 Laufer et al. Oct 2000 A
6152899 Farley et al. Nov 2000 A
6165172 Farley et al. Dec 2000 A
6179832 Jones et al. Jan 2001 B1
6200312 Zikorus et al. Mar 2001 B1
6231507 Zikorus et al. May 2001 B1
6237606 Zikorus et al. May 2001 B1
6238393 Mulier et al. May 2001 B1
6258084 Goldman et al. Jul 2001 B1
6263248 Farley et al. Jul 2001 B1
6322559 Daulton et al. Nov 2001 B1
6398780 Farley et al. Jun 2002 B1
6485500 Kokish et al. Nov 2002 B1
6508815 Strul et al. Jan 2003 B1
6712815 Sampson et al. Mar 2004 B2
6813520 Truckai et al. Nov 2004 B2
Foreign Referenced Citations (3)
Number Date Country
40 01 086 Jan 1990 DE
WO9958070 Nov 1999 WO
WO 0197897 Dec 2001 WO
Related Publications (1)
Number Date Country
20040143251 A1 Jul 2004 US
Provisional Applications (1)
Number Date Country
60261321 Jan 2001 US
Divisions (1)
Number Date Country
Parent 10052157 Jan 2002 US
Child 10751592 US